UNITED STATES - U.S. Securities and Exchange...
VIVUS ANNOUNCES POSITIVE RESULTS FROM PHASE 3 STUDY OF AVANAFIL IN ERECTILE DYSFUNCTION; DATA DEMONSTRATE ROBUST EFFICACY, FAVORABLE SIDE-EFFECT PROFILE Results Underscore Differentiating Profile; Indicate Significant ......